Neuropsychological and psychosocial assessment of small and non-small lung cancer patients: a study protocol DOI Creative Commons

Benedetta Capetti,

Lorenzo Conti, Chiara Marzorati

et al.

Frontiers in Psychology, Journal Year: 2025, Volume and Issue: 16

Published: April 30, 2025

Early diagnosis and effective treatments have favored the survival of cancer patients but also generated adverse consequences including cognitive impairment psychological distress, which are related to both disease progression side effects pharmacological agents. However, there is little data in literature concerning such with lung cancer. Here, we describe protocol a study aiming investigate occurrence non-small-cell small-cell undergoing adjuvant therapies or surgery year following enrollment. This longitudinal will recruit around 200 patients. To explore profile pre- post-oncological treatment, evaluation be administered each patient at baseline (T0), 4 (T1), 12 months (T2) after end treatments. A screening assessed Montreal Cognitive Assessment Mini-Mental State Examination. Executive functions investigated Frontal Battery, Stroop Color Word test phonemic fluency test. Memory learning examined Rey's auditory verbal test, whereas working memory Digit Span Corsi Block-tapping Test. Finally, attention Trail Making Test Symbol Modalities In addition, perceived impairment, anxious depressive symptoms, reserve, sleep patterns, patient's quality life using self-report tools. The identified by adopting criteria proposed International Cognition Cancer Task Force. trial received approval from ethical committee Institutes Scientific Research Healthcare, IRCCS, European Institute Oncology (UID_IEO 2027). results could relevant implications for managing its impact on Through systematic assessment associated risk factors, this aims provide valuable insights into clinical practice, enhancing development neuropsychological protocols.

Language: Английский

Neuropsychological and psychosocial assessment of small and non-small lung cancer patients: a study protocol DOI Creative Commons

Benedetta Capetti,

Lorenzo Conti, Chiara Marzorati

et al.

Frontiers in Psychology, Journal Year: 2025, Volume and Issue: 16

Published: April 30, 2025

Early diagnosis and effective treatments have favored the survival of cancer patients but also generated adverse consequences including cognitive impairment psychological distress, which are related to both disease progression side effects pharmacological agents. However, there is little data in literature concerning such with lung cancer. Here, we describe protocol a study aiming investigate occurrence non-small-cell small-cell undergoing adjuvant therapies or surgery year following enrollment. This longitudinal will recruit around 200 patients. To explore profile pre- post-oncological treatment, evaluation be administered each patient at baseline (T0), 4 (T1), 12 months (T2) after end treatments. A screening assessed Montreal Cognitive Assessment Mini-Mental State Examination. Executive functions investigated Frontal Battery, Stroop Color Word test phonemic fluency test. Memory learning examined Rey's auditory verbal test, whereas working memory Digit Span Corsi Block-tapping Test. Finally, attention Trail Making Test Symbol Modalities In addition, perceived impairment, anxious depressive symptoms, reserve, sleep patterns, patient's quality life using self-report tools. The identified by adopting criteria proposed International Cognition Cancer Task Force. trial received approval from ethical committee Institutes Scientific Research Healthcare, IRCCS, European Institute Oncology (UID_IEO 2027). results could relevant implications for managing its impact on Through systematic assessment associated risk factors, this aims provide valuable insights into clinical practice, enhancing development neuropsychological protocols.

Language: Английский

Citations

0